In Brief: Molecular Biosystems FS069
Executive Summary
Molecular Biosystems FS069: Ultrasound contrast agent will be reviewed by FDA's Medical Imaging Drugs Advisory Committee on Feb. 24 for use with 2-D echocardiography in cardiovascular imaging...